• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Blue Cross NC Lowers Average 2021 ACA Rates for Individuals

Article

Blue Cross NC’s third straight year of rate reductions since 2018.

Durham, N.C. – Blue Cross and Blue Shield of North Carolina (Blue Cross NC) will be reducing rates by an average of 1% statewide for 2021 Affordable Care Act (ACA) plans offered to individuals. This is the third straight year that Blue Cross NC has lowered rates—a 3-year total reduction since 2018 of over $380 million.

“We’re pleased to make health insurance more affordable for North Carolinians who buy their own coverage from the individual market,” said Tunde Sotunde, president and CEO of Blue Cross NC. “Our customers can continue to count on us as they navigate challenges during this pandemic and beyond. We will again offer ACA plans in all 100 North Carolina counties, as we have since the beginning of the ACA in 2014.”

The decrease is a result of the company’s efforts to hold down costs while ensuring high-quality health care for members.

2021 rates take into account 2 unexpected and fluid circumstances—the ongoing coronavirus disease 2019 pandemic and customers’ deferral of non-urgent care. After many customers deferred care in March through May, a large number have recently resumed elective procedures, which is reflected in a significant increase in customers’ medical claims for June and July.

Learn more.

Related Videos
Dr Padma Sripada, Columbia Internal Medicine
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Joshua K. Sabari, MD< NYU Langone Perlmutter Cancer Center
dr marisa mcginley
Leslie Busby, MD, Rocky Mountain Cancer Centers
Camilla Levister
dr daniel ontaneda
Sudipto Mukherjee, MD, PhD, MPH, hematology and medical oncology, Cleveland Clinic
Kiana Mehring, MBA, director of strategic partnerships, managed care at Florida Cancer Specialists & Research Institute (FCS)
Sudipto Mukherjee, MD, PhD, MPH, hematology and medical oncology, Cleveland Clinic
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.